# Neoadjuvant–Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/neoadjuvant-adjuvant-or-adjuvant-only-pembrolizumab-in-advanced-melanoma/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Sapna P. Patel,Megan Othus,Yuanbin Chen,G. Paul Wright,Kathleen J. Yost,John Hyngstrom,Siwen Hu‐Lieskovan,Christopher D. Lao,Leslie A. Fecher,Thach‐Giao Truong,Jennifer L. Eisenstein,Sunandana Chandra,Jeffrey A. Sosman,Kari Kendra,Richard C. Wu,Craig Devoe,Gary B. Deutsch,Aparna Hegde,Maya Khalil,Ankit Mangla,Amy M. Reese,Merrick I. Ross,Andrew Poklepovic,Giao Q. Phan,Adedayo A. Onitilo,Demet G. Yasar,Benjamin Powers,Gary C. Doolittle,Gino K. In,Niels Kokot,Geoffrey T. Gibney,Michael B. Atkins,Montaser Shaheen,James Warneke,Alexandra P. Ikeguchi,Jose Eugenio Najera,Bartosz Chmielowski,Joseph G. Crompton,Justin D. Floyd,Eddy C. Hsueh,Kim Margolin,Warren Chow,Kenneth F. Grossmann,Eliana Dietrich,Víctor G. Prieto,Michael Lowe,Elizabeth I. Buchbinder,John M. Kirkwood,Larissa A. Korde,James Moon,Elad Sharon,Vernon K. Sondak,Antoni Ribas |
| Citations | 859 |
| DOI | 10.1056/nejmoa2211437 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | green |
| OA URL | https://escholarship.org/content/qt87x612c2/qt87x612c2.pdf?t=s12nlq |
| OpenAlex ID | https://openalex.org/W4322718735 |
| PMID | 36856617 |
| Type | article |
| Year | 2023 |

## Paper authors

- [Leslie A. Fecher](https://scholariq.org/researchers/leslie-a-fecher/)
- [G. Paul Wright](https://scholariq.org/researchers/g-paul-wright/)

## Paper journal

- [New England Journal of Medicine](https://scholariq.org/journals/new-england-journal-of-medicine/)

## Paper primary topic

- [Cutaneous Melanoma Detection and Management](https://scholariq.org/topics/cutaneous-melanoma-detection-and-management/)

## Paper topics

- [Cutaneous Melanoma Detection and Management](https://scholariq.org/topics/cutaneous-melanoma-detection-and-management/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Melanoma and MAPK Pathways](https://scholariq.org/topics/melanoma-and-mapk-pathways/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.